It is widely recognised that lactoferrin reduces gastrointestinal inflammation, caused by infection and dietary intolerances, and the undesirable consequences of inflammation, such as increased membrane permeability and tissue damage in the GI tract.
- Forums
- ASX - By Stock
- JAT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-89
-
-
- There are more pages in this discussion • 182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
0.035(9.59%) |
Mkt cap ! $58.28M |
Open | High | Low | Value | Volume |
37.0¢ | 41.5¢ | 37.0¢ | $24.98K | 63.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3000 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 731 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1801171 | 0.056 |
17 | 2403917 | 0.055 |
3 | 190000 | 0.054 |
2 | 220000 | 0.053 |
1 | 50000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 95645 | 1 |
0.058 | 109100 | 2 |
0.059 | 626122 | 3 |
0.060 | 600000 | 3 |
0.061 | 371000 | 4 |
Last trade - 15.51pm 03/12/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |